Nalaganje...
A New Oral Testosterone Undecanoate Formulation Restores Testosterone to Normal Concentrations in Hypogonadal Men
CONTEXT: A novel formulation of oral testosterone (T) undecanoate (TU) was evaluated in a phase 3 clinical trial. OBJECTIVE: Determine efficacy, short-term safety, and alignment of new oral TU formulation with current US approval standards for T replacement therapy. DESIGN: Randomized, active-contro...
Shranjeno v:
| izdano v: | J Clin Endocrinol Metab |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Oxford University Press
2020
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7282712/ https://ncbi.nlm.nih.gov/pubmed/32382745 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/clinem/dgaa238 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|